Endometriosis occurs when tissue resembling the endometrial lining grows outside the uterus — on the ovaries, fallopian tubes, bowel, or pelvic peritoneum.
These ectopic lesions behave like endometrial tissue. They respond to hormonal cycles, bleed, and trigger inflammation. Over time, that inflammation drives the formation of adhesions and scar tissue that distort pelvic anatomy and impair fertility.
Endometriosis affects an estimated 190 million women worldwide, yet the two most common treatments — hormonal suppression and laparoscopic surgery — address symptoms without correcting the underlying tissue dysfunction.
Surgery carries a recurrence rate of approximately 40–50% within five years. Hormonal therapy works only while it’s being taken.
Stem cell therapy is being studied as an approach that targets the biological mechanism itself: abnormal tissue growth, chronic inflammation, and impaired endometrial repair.
While current research remains in preclinical or early clinical phases, we’re presenting a guide to the science behind stem cell injections for endometriosis pain.
What Is Stem Cell Therapy for Endometriosis?
Stem cell therapy for endometriosis is a regenerative medicine approach that uses specialized cells — primarily mesenchymal stem cells (MSCs) — to reduce endometrial lesion formation, suppress abnormal immune responses, and support tissue repair.
In early-phase studies, MSC-based interventions have reduced lesion size and shown immunomodulatory effects that hormonal therapies do not replicate.
Endometriosis and the Link to Immune Dysfunction
The condition is not simply a hormonal imbalance. Research increasingly points to immune dysfunction — specifically, an impaired ability of peritoneal macrophages and natural killer cells to clear ectopic cells — as a core driver.
This is the gap stem cell research is attempting to close: correcting the immune environment and damaged tissue, not just suppressing hormones.
Mesenchymal Stem Cells (MSCs) Offering Hope of Lasting Endometriosis Pain Relief
Mesenchymal stem cells, multipotent stromal cells derived from bone marrow, adipose tissue, or umbilical cord, are the most clinically advanced option in endometriosis research.
Their appeal comes from a well-documented immunomodulatory profile: MSCs suppress T-cell proliferation, reduce TNF-α and IL-6 expression, and shift macrophage polarization from pro-inflammatory (M1) to anti-inflammatory (M2) phenotypes.
Studies have shown that MSCs can mitigate endometriosis-associated chronic inflammatory reactions by reducing CD68-positive macrophages and downregulating proinflammatory cytokine expression. The mechanism appears to be paracrine rather than direct cell engraftment, which means MSCs don’t need to survive long-term to produce therapeutic effects — a significant advantage for safety profiling.
The Biological Mechanism — What Stem Cells Are Designed to Do
MSCs work through two primary pathways:
1. Paracrine signaling
MSCs secrete anti-inflammatory cytokines that suppress the pro-inflammatory environment sustaining ectopic lesions.
2. Angiogenesis inhibition
MSCs release factors that reduce the formation of new blood vessels that feed lesion growth.
Neither mechanism is a cure. The goal in current research is lesion reduction and symptomatic relief without the hormonal side effects of GnRH agonists or the recurrence risk of surgery.
Current Clinical Evidence — What Trials Have Found So Far
A study published in the Frontiers Medical Journal found that MSCs represent a highly promising avenue for treating endometriosis. The data showed that by regulating the localized immune response and dampening chronic inflammation, MSCs target the underlying immunological failures that allow endometriosis to thrive.
MSCs have been shown to significantly reduce the size of endometriotic lesions and decrease the expression of pro-inflammatory cytokines and macrophages
| Factor | Hormonal Therapy | Laparoscopic Surgery | Stem Cell Therapy |
| Mechanism | Suppresses estrogen; halts cycle | Physically removes lesions | Immunomodulation + tissue repair |
| Recurrence rate | Returns when stopped | ~40–50% within 5 years | [Insufficient long-term data] |
| Fertility impact | Contraceptive effect during use | Risks to ovarian reserve | Neutral to potentially positive in early data |
| Side effects | Bone density loss, mood effects, and menopause symptoms | Surgical risks, adhesion formation | Largely unknown; early data suggest well-tolerated |
| Availability | Widely available | Widely available | Stem Cell Pain Relief Treatments Available in Florida |
The Promise of Regenerative Therapy
Rather than just managing symptoms through “medical menopause” or removing tissue surgically, stem cell therapy targets the cellular environment.
Mesenchymal Stem Cells (MSCs) act as the body’s natural repair system. When directed toward endometriotic lesions, early clinical data and robust animal studies show they can dramatically reduce inflammation, calm abnormal immune responses, and significantly lower pelvic pain scores. For many women, this represents a hopeful shift toward enduring pain relief rather than just managing chronic illness.
Who Is a Suitable Candidate for Endometriosis Stem Cell Therapy?
Because regenerative therapy for endometriosis is still an emerging field, it is most often explored by patients who require more advanced, alternative care. Suitable candidates typically include:
- Treatment-resistant patients: Those who have not found lasting relief from traditional hormonal therapies or repeated laparoscopic excision surgeries.
- Patients facing fertility challenges: Individuals dealing with poor endometrial receptivity or uterine scarring (such as Asherman’s Syndrome) alongside their endometriosis.
- Those seeking alternatives to systemic hormones: Women who cannot tolerate the severe side effects of GnRH agonists and want a highly targeted, anti-inflammatory approach.
- Patients with severe dysmenorrhea: Those whose daily quality of life is heavily impacted by chronic pelvic pain and inflammation.
Book a Free Consultation to Find Out If Stem Cell Treatment is Suitable for Your Endometriosis Symptoms
STEMS Health is Florida’s leader in stem cell treatments and cutting-edge regenerative medicine research. We work with women across the United States in evaluating their symptoms, identifying the potential causes, and building tailored pain relief roadmaps.
Choose STEMS for:
- One-on-one consultations with clinicians experienced in regenerative gynecology
- Support identifying and evaluating active clinical trials
- Coordination between your existing care team and emerging treatment options
Schedule your free online consultation today to speak with our board-certified stem cell doctors from your home.
Answers to Frequent Questions on Stem Cells for Endometriosis Pain
What type of stem cells are most promising for endometriosis?
Mesenchymal stem cells (MSCs) — particularly those derived from bone marrow or adipose tissue — have the most clinical evidence to date. They work primarily through anti-inflammatory paracrine signaling rather than direct tissue replacement. Endometrial MSCs (eMSCs) are a secondary area of active research with potential for autologous sourcing.
Can stem cells cure endometriosis?
No current evidence supports a curative effect. Research aims are focused on lesion reduction, pain relief, and improved fertility outcomes — not eradication.
The condition’s recurrence-prone nature and immune complexity make a single-treatment cure biologically unlikely in the near term.
How is stem cell therapy different from current endometriosis treatments?
Hormonal therapies and surgery manage symptoms or remove visible lesions; neither corrects the immune dysfunction that allows ectopic tissue to establish and persist.
Stem cell therapy targets the inflammatory microenvironment directly — a mechanistically distinct approach that, if validated, could reduce recurrence rather than delay it.
Where can I find clinical trials for stem cells and endometriosis?
Search ClinicalTrials.gov using the condition “endometriosis” and the term “stem cells.” Filter for actively recruiting trials. Confirm that any trial has a valid NCT number and institutional sponsorship before inquiring. For pain relief options, speak with the stem cell doctors at STEMS Health.
Sources:
Habata, S., Mamillapalli, R., Ucar, A., & Taylor, H. S. (2023). Donor Mesenchymal Stem Cells Program Bone Marrow, Altering Macrophages, and Suppressing Endometriosis. Stem Cells International, 2023, 1–12. https://doi.org/10.1155/2023/1598127
Mutlu, L., Hufnagel, D., & Taylor, H. S. (2015). The Endometrium as a Source of Mesenchymal Stem Cells for Regenerative Medicine1. Biology of Reproduction, 92. https://doi.org/10.1095/biolreprod.114.126771
Tosun, A. (n.d.). From pain to policy: Improving endometriosis awareness, diagnosis, and treatment. PLOS Medicine. https://journals.plos.org/plosmedicine/article?id=10.1371/journal.pmed.1004981
Yang, F., Liu, B., Xu, L., & Liu, H. (2020). Age at surgery and recurrence of ovarian endometrioma after conservative surgery: a meta-analysis including 3125 patients. Archives of Gynecology and Obstetrics, 302, 23–30. https://doi.org/10.1007/s00404-020-05586-3
Zhao-Di, W. (n.d.). Role and mechanism of mesenchymal stem cells in endometrial receptivity remodeling. Frontiers in Cell and Developmental Biology. https://www.frontiersin.org/journals/cell-and-developmental-biology/articles/10.3389/fcell.2026.1724597/full
